Virginia Retirement Systems’s Karyopharm Therapeutics KPTI Stock Holding History

Virginia Retirement Systems’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,133	Closed	-$165K	–	991
2023 Q2	$165K	Sell	6,133 -2,707	-31%	-$117K	﹤0.01%	934
2023 Q1	$516K	Buy	8,840 +2,753	+45%	+$136K	0.01%	729
2022 Q4	$310K	Buy	6,087 +4,680	+333%	+$324K	﹤0.01%	955
2022 Q3	$115K	Buy	+1,407	New	+$105K	﹤0.01%	1103
2022 Q1	–	Sell	-2,873	Closed	-$277	–	1173
2021 Q4	$277	Sell	2,873 -5,280	-65%	-$526K	﹤0.01%	999
2021 Q3	$712K	Buy	8,153 +6,586	+420%	+$684K	0.01%	717
2021 Q2	$243K	Buy	+1,567	New	+$227K	﹤0.01%	962

Other funds holding KPTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virginia Retirement Systems's KPTI Position: Q3 2023 in Review

Virginia Retirement Systems sold out of Karyopharm Therapeutics (KPTI) in Q3 2023, closing a stake of 6,133 shares — an estimated $165K sold.

Virginia Retirement Systems first reported a position in KPTI in Q2 2021 and held it in 7 quarters. The position peaked at $712K in Q3 2021. 118 funds tracked by Wall St. Rank hold KPTI as of Q3 2023.

Virginia Retirement Systems reported no remaining Karyopharm Therapeutics position as of Q3 2023 after selling out during the quarter.
Virginia Retirement Systems sold 6,133 Karyopharm Therapeutics shares in Q3 2023, an estimated $165K.
Virginia Retirement Systems first reported a position in Karyopharm Therapeutics in Q2 2021 and held it in 7 quarters.
Virginia Retirement Systems's Karyopharm Therapeutics position peaked at $712K in Q3 2021.
118 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.